Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Stopped study drug was removed from the market and low enrollment.

Conditions

• Breast Cancer

Interventions

• BIOLOGICAL: filgrastim
• DRUG: capecitabine
• DRUG: celecoxib
• DRUG: cyclophosphamide
• DRUG: docetaxel
• DRUG: doxorubicin hydrochloride
• GENETIC: gene expression analysis
• GENETIC: polymorphism analysis
• GENETIC: protein expression analysis
• GENETIC: reverse transcriptase-polymerase chain reaction
• OTHER: imaging biomarker analysis
• OTHER: immunohistochemistry staining method
• OTHER: laboratory biomarker analysis
• OTHER: pharmacogenomic studies
• PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging
• PROCEDURE: needle biopsy
• PROCEDURE: neoadjuvant therapy
• PROCEDURE: radiomammography
• PROCEDURE: ultrasound imaging

Sponsor

University of Nebraska

Collaborators

• [object Object]